+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 33 Pages
  • January 2023
  • GlobalData
  • ID: 1936323
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and cancerous diseases. Its lead product candidate includes Inecalcitol, a vitamin D receptor agonist being assessed for various cancer indications including prostate cancer, chronic lymphocytic leukemia, and moderate to severe psoriasis. The company is also investigating the action of deubiquitinating enzymes (DUB) in the recycling of oncoproteins and the utility of proprietary patented DUB inhibitors against various cancer indications. Hybrigenics employs its expertise in DUBs to discover and develop new treatments. It also offers specialized scientific services for validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Hybrigenics SA - Key Facts
  • Hybrigenics SA - Key Employees
  • Hybrigenics SA - Key Employee Biographies
  • Hybrigenics SA - Major Products and Services
  • Hybrigenics SA - History
  • Hybrigenics SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Hybrigenics SA - Business Description
  • R&D Overview
  • Hybrigenics SA - Corporate Strategy
  • Hybrigenics SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Hybrigenics SA - Strengths
  • Hybrigenics SA - Weaknesses
  • Hybrigenics SA - Opportunities
  • Hybrigenics SA - Threats
  • Hybrigenics SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Hybrigenics SA, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Hybrigenics SA, Key Facts
  • Hybrigenics SA, Key Employees
  • Hybrigenics SA, Key Employee Biographies
  • Hybrigenics SA, Major Products and Services
  • Hybrigenics SA, History
  • Hybrigenics SA, Subsidiaries
  • Hybrigenics SA, Key Competitors
  • Hybrigenics SA, Annual Ratios
  • Hybrigenics SA, Interim Ratios
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Hybrigenics SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Hybrigenics SA, Performance Chart (2017 - 2021)
  • Hybrigenics SA, Ratio Charts
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hybrigenics SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Vaxon Biotech
  • Transgene SA
  • Quantum Genomics SA
  • Qiagen Marseille SA
  • Innate Pharma SA
  • Erytech Pharma SA
  • Bioquanta SA